Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping

NeuroImage

Volumn 49, Issue 3, 2010, Pages 2158-2162

  Ulmer, Stephan ^a   Hartwigsen, Gesa ^a   Riedel, Christian ^a   Jansen, Olav ^a   Mehdorn, H Maximilian ^a   Nabavi, Arya ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Brain tumor; Correlation; DSC MRI; Intraoperative MRI; Perfusion

Indexed keywords

GADOLINIUM PENTETATE;

ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN DAMAGE; BRAIN PERFUSION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GLIOBLASTOMA; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; MEDICAL DECISION MAKING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELIABILITY; TIME;

BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS;

EID: 71849084938     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.10.084     Document Type: Article

References (32)

1. Belliveau J.W., Rosen B.R., Kantor H.L., Rzedzian R.R., Kennedy D.N., McKinstry R.C., Vevea J.M., Cohen M.S., Pykett I.L., and Brady T.J. Functional cerebral imaging by susceptibility-contrast NMR. Magn. Reson. Med. 14 (1990) 538-546
2. Boxerman J.L., Schmainda K.M., and Weisskoff R.M. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am. J. Neuroradiol. 27 (2006) 859-867
3. Brix G., Semmler W., Port R., Schad L.R., Layer G., and Lorenz W.J. Pharmacokinetic parameters in CNS Gd.DTPA-enhanced MR imaging. J. Comput. Assist. Tomogr. 15 (1991) 621-628
4. Bullock P.R., Mansfield P., Gowland P., Worthington B.S., and Firth J.L. Dynamic imaging of contrast enhancement in brain tumors. Magn. Reson. Med. 19 (1991) 293-298
5. Caseiras G.B., Thornton J.S., Yousry T., Benton C., Rees J., Waldman A.D., and Jäger H.R. Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?. AJNR Am. J. Neuroradiol. 29 6 (2008) 1140-1141
6. Conturo T.E., Akbudak E., Kotys M.S., Chen M.L., Chun S.J., Hsu R.M., Sweeney C.C., and Markham J. Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J. Magn. Reson. Imaging 22 (2005) 697-703
7. Covarrubias D.J., Rosen B.R., and Lev M.H. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9 (2004) 528-537
8. Edelman R.R., Mattle H.P., Atkinson D.J., Hill T., Finn J.P., Mayman C., Ronthal M., Hoogewoud H.M., and Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5T. Radiology 176 (1990) 211-220
9. Emblem K.E., Nedregaard B., Nome T., Due-Tonnessen P., Hald J.K., Scheie D., Borota O.C., Cvancarova M., and Bjornerud A. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 247 (2008) 808-817
10. Donahue K.M., Weisskoff R.M., Parmalee D.J., Callahan R.J., Wilkinson R.A., Mandeville J.B., and Rosen B.R. Dynamic Gd-DTPA enhancement MRI measurement of tissue cell volume fraction. Magn. Reson. Med. 34 (1995) 423-432
11. Donahue K.M., Krouwer H.G., Rand S.D., Pathak A.P., Marszalkowski C.S., Censky S.C., and Prost R.W. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn. Reson. Med. 43 (2000) 845-853
12. Galanis E., Buckner J.C., Maurer M.J., Sykora R., Castillo R., Ballman K.V., and Erickson B.J. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro-oncol 8 (2006) 156-165
13. Hartmann M., Heiland S., Harting I., Tronnier V.M., Sommer C., Ludwig R., and Sartor K. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci. Lett. 338 (2003) 119-122
14. Knauth M., Aras N., Wirtz C.R., Dorfler A., Engelhorn T., and Sartor K. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR AM. J. Neuroradiol. 20 (1999) 1547-1553
15. Knopp E.A., Cha S., Johnson G., Mazumdar A., Golfinos J.G., Zagzag D., Miller D.C., Kelly P.J., and Kricheff I.I. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211 (1999) 791-798
16. Law M., Cha S., Knopp E.A., Johnson G., Arnett J., and Litt A.W. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222 (2002) 715-721
17. Law M., Oh S., Babb J.S., Wnag E., Inglese M., Zagzag D., Knopp E.A., and Johnson G. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging-prediction of patient clinical response. Radiology 238 (2006) 658-667
18. Lev M.L., Ozsunar Y., Henson J.W., Rasheed A.A., Barest G.D., Harsh IV G.R., Fitzek M.M., Chiocca E.A., Rabinov J.D., Csavoy A.N., Rosen B.R., Hochberg F.H., Schaefer P.W., and Gonzalez R.G. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared to conventional contrast enhanced MRI: confounding effect of elevated relative cerebral blood volume of oligodendrogliomas. AJNR Am. J. Neuroradiol. 25 (2004) 214-221
19. Li K.L., Zhu X.P., Waterton J., and Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J. Magn. Reson. Imaging 12 (2000) 347-357
20. Ludemann L., Warmuth C., Plotkin M., Forschler A., Gutberlet M., Wust P., and Amthauer H. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H215O positron emission tomography. Eur. J. Radiol. 70 3 (2009) 465-474
21. Nabavi A., Black P.M., Gering D.T., Westin C.F., Mehta V., Pergolizzi Jr. R.S., Ferrant M., Warfield S.K., Hata N., Schwartz R.B., Wells III W.M., Kikinis R., and Jolesz F.A. Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 48 (2001) 787-797
22. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J. Magn. Reson. Imaging 22 (2005) 710-717
23. Parker G.J., Suckling J., Tanner S.F., Padhani A.R., Revell P.B., Husband J.E., and Leach M.O. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J. Magn. Reson. Imaging 7 (1997) 564-574
24. Provenzale J.M., Wang G.R., Brenner T., Petrella J.R., and Sorensen A.G. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJRAm. J. Roentgenol. 178 (2002) 711-716
25. Rosen B.R., Belliveau J.W., Vevea J.M., and Brady T.J. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14 (1990) 249-265
26. Sorensen A.G., Copen W.A., Ostergaard L., Buonanno F.S., Gonzalez R.G., Rordorf G., Rosen B.R., Schwamm L.H., Weisskoff R.M., and Koroshert W.J. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean transit time. Radiology 210 (1999) 519-527
27. Sugahara T., Korogi Y., Kochi M., Ikushima I., Hirai T., Okuda T., Shigematsu Y., Liang L., Ge Y., Ushio Y., and Takahashi M. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am. J. Roentgenol. 171 (1998) 1479-1486
28. Sugahara T., Korogi Y., Tomiguchi S., Shigematsu Y., Ikushima I., Kira T., Liang L., Ushio Y., and Takahashi M. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am. J. Neuroradiol. 21 (2000) 901-909
29. Ulmer S., Helle M., Jansen O., Mehdorn H.M., and Nabavi A. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI)-technical considerations and feasibility. Neuroimage 45 1 (2009) 38-43
30. Villringer A., Rosen B.R., Belliveau J.W., Ackerman J.L., Lauffer R.B., Buxton R.B., Chao Y.S., Wedeen V.J., and Brady T.J. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6 (1988) 164-174
31. Wick W., Stupp R., Beule A.C., Bromberg J., Wick A., Ernemann U., Platten M., Marosie C., Mason W.P., van den bent M., Weller M., Rorden C., Karnath H.O., and European Organisation for Research and Treatment of Cancer and the National Cancer Institute of Canada Clinical Trials Group. A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro-oncol 10 6 (2008) 1024-1919
32. Worthington B.S., Bullock P.R., Stehling M., Gowland P., Firth J.L., and Mansfield P. Clinical experience with contrast enhanced echo-planar imaging of the brain. Magn. Reson. Med. 22 (1991) 255-258